Cross-kingdom inhibition of breast cancer growth by plant miR159

Cell Research

Volumn 26, Issue 2, 2016, Pages 217-228

  Chin, Andrew R ^a   Fong, Miranda Y ^a   Somlo, George ^a   Wu, Jun ^a   Swiderski, Piotr ^a   Wu, Xiwei ^a   Wang, Shizhen Emily ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

breast cancer; cross kingdom regulation; miR159; TCF7

Indexed keywords

MICRORNA; PLANT RNA;

ANIMAL; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; MICE; MICRORNAS; RNA, PLANT; SIGNAL TRANSDUCTION;

EID: 84957439674     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2016.13     Document Type: Article

References (57)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
2. Chen X. Small RNAs in development-insights from plants. Curr Opin Genet Dev 2012; 22:361-367.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
4. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-7070.
5. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-10518.
6. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-Derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110:13-21.
7. Wu X, Somlo G, Yu Y, et al. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med 2012; 10:42.
8. Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2009; 2:89.
9. Redis RS, Calin S, Yang Y, You MJ, Calin GA. Cell-To-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther 2012; 136:169-174.
10. Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 2012; 32:326-348.
11. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108:5003-5008.
12. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883-891.
13. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-1476.
14. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659.
15. Vickers KC, Remaley AT. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23:91-97.
16. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010; 38:7248-7259.
17. Fong MY, Zhou W, Liu L, et al. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 2015; 17:183-194.
18. Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25:501-515.
19. Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 2015; 17:816-826.
20. Chen X. Small RNAs and their roles in plant development. Annu Rev Cell Dev Biol 2009; 25:21-44.
21. Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012; 22:107-126.
22. Zhou Z, Li X, Liu J, et al. Honeysuckle-Encoded atypical microRNA2911 directly targets influenza A viruses. Cell Res 2015; 25:39-49.
23. Yu B, Yang Z, Li J, et al. Methylation as a crucial step in plant microRNA biogenesis. Science 2005; 307:932-935.
24. Mlotshwa S, Pruss GJ, MacArthur JL, et al. A novel chemopreventive strategy based on therapeutic microRNAs produced in plants. Cell Res 2015; 25:521-524.
25. Tosar JP, Rovira C, Naya H, Cayota A. Mining of public sequencing databases supports a non-Dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS. RNA 2014; 20:754-757.
26. Zhang Y, Wiggins BE, Lawrence C, Petrick J, Ivashuta S, Heck G. Analysis of plant-Derived miRNAs in animal small RNA datasets. BMC Genomics 2012; 13:381.
27. Snow JW, Hale AE, Isaacs SK, Baggish AL, Chan SY. Ineffective delivery of diet-Derived microRNAs to recipient animal organisms. RNA Biol 2013; 10:1107-1116.
28. Witwer KW, McAlexander MA, Queen SE, Adams RJ. Real-Time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: limited evidence for general uptake of dietary plant xenomiRs. RNA Biol 2013; 10:1080-1086.
29. Baier SR, Nguyen C, Xie F, Wood JR, Zempleni J. MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers. J Nutr 2014; 144:1495-1500.
30. Dickinson B, Zhang Y, Petrick JS, Heck G, Ivashuta S, Marshall WS. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013; 31:965-967.
31. Chen X, Zen K, Zhang CY. Reply to Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013; 31:967-969.
32. Wang K, Li H, Yuan Y, et al. The complex exogenous RNA spectra in human plasma: an interface with human gut biota? PLoS One 2012; 7:e51009.
33. Lukasik A, Zielenkiewicz P. In silico identification of plant miRNAs in mammalian breast milk exosomes-a small step forward? PLoS One 2014; 9:e99963.
34. Liang G, Zhu Y, Sun B, et al. Assessing the survival of exogenous plant microRNA in mice. Food Sci Nutr 2014; 2:380-388.
35. Liang H, Zhang S, Fu Z, et al. Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma. J Nutr Biochem 2015; 26:505-512.
36. Yang J, Farmer LM, Agyekum AA, Hirschi KD. Detection of dietary plant-based small RNAs in animals. Cell Res 2015; 25:517-520.
37. Munafo DB, Robb GB. Optimization of enzymatic reaction conditions for generating representative pools of cDNA from small RNA. RNA 2010; 16:2537-2552.
38. Li J, Yang Z, Yu B, Liu J, Chen X. Methylation protects miRNAs and siRNAs from a 3'-End uridylation activity in Arabidopsis. Curr Biol 2005; 15:1501-1507.
39. Allen RS, Li J, Stahle MI, Dubroue A, Gubler F, Millar AA. Genetic analysis reveals functional redundancy and the major target genes of the Arabidopsis miR159 family. Proc Natl Acad Sci USA 2007; 104:16371-16376.
40. Cambronne XA, Shen R, Auer PL, Goodman RH. Capturing microRNA targets using an RNA-induced silencing complex (RISC)-Trap approach. Proc Natl Acad Sci USA 2012; 109:20473-20478.
41. Benhaj K, Akcali KC, Ozturk M. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006; 15:701-707.
42. Johnson JP, Kumar P, Koulnis M, Patel M, Simin K. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer. Cancer Genomics Proteomics 2014; 11:115-126.
43. Hrdlickova R, Nehyba J, Bargmann W, Bose HR Jr. Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway. PLoS One 2014; 9:e86990.
44. Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121:2750-2767.
45. Bilir B, Kucuk O, Moreno CS. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med 2013; 11:280.
46. Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/ TCF action in development and disease. Oncogene 2006; 25:7492-7504.
47. Guan XY, Xu J, Anzick SL, Zhang H, Trent JM, Meltzer PS. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res 1996; 56:3446-3450.
48. Lee SK, Anzick SL, Choi JE, et al. A nuclear factor, ASC-2, as a cancer-Amplified transcriptional coactivator essential for ligand-Dependent transactivation by nuclear receptors in vivo. J Biol Chem 1999; 274:34283-34293.
49. Mahajan MA, Samuels HH. Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development. Nucl Recept Signal 2008; 6:e002.
50. Martin NL, Saba-El-Leil MK, Sadekova S, Meloche S, Sauvageau G. EN2 is a candidate oncogene in human breast cancer. Oncogene 2005; 24:6890-6901.
51. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69:119-128.
52. Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene 1999; 18:2967-2987.
53. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999; 13:2678-2690.
54. Reynolds JE, Yang T, Qian L, et al. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994; 54:6348-6352.
55. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22:659-661.
56. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol 2003; 13:680-685.
57. Orom UA, Lund AH. Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods 2007; 43:162-165.